Computational design of actinium-225 chelators for use in targeted alpha therapy

被引：0
|
作者：
Morgenstern, Amanda [1 ]
Lilley, Laura [1 ]
Stein, Benjamin [1 ]
Kozimor, Stosh [1 ]
Batista, Enrique [1 ]
Yang, Ping [1 ]
机构：
[1] Los Alamos Natl Lab, Los Alamos, NM USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
22-NUCL
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Challenges for using Actinium-225 in radionuclide therapy
    Atcher, Robert W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [22] Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer
    Schatz, Christoph A.
    Zitzmann-Kolbe, Sabine
    Moen, Ingrid
    Klotz, Monika
    Nair, Shankari
    Stargard, Stefan
    Bjerke, Roger M.
    Biseth, Katrine Wickstrom
    Feng, Yuan Zeng
    Indrevoll, Bard
    Cruciani, Veronique
    Karlsson, Jenny
    Haendler, Bernard
    Nielsen, Carsten H.
    Alfsen, Maria Z.
    Hammer, Stefanie
    Hennekes, Hartwig
    Cuthbertson, Alan
    Hagemann, Urs B.
    Larsen, Asmund
    CLINICAL CANCER RESEARCH, 2024, 30 (11) : 2531 - 2544
  • [23] Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy
    Brown, Victoria
    Rodriguez-Rodriguez, Cristina
    Zhang, Chengcheng
    Maskell, Keiran
    Benard, Francois
    Ramogida, Caterina
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S101 - S101
  • [24] Production of actinium-225 for alpha particle mediated radioimmunotherapy
    Boll, RA
    Malkemus, D
    Mirzadeh, S
    APPLIED RADIATION AND ISOTOPES, 2005, 62 (05) : 667 - 679
  • [25] Development of iodine-123-based PSMA radiohybrid conjugates as a diagnostic counterpart for targeted alpha therapy with actinium-225
    Kroenke, T.
    Ullrich, M.
    Zarschler, K.
    Reissig, F.
    Pietzsch, J.
    Kopka, K.
    Stadlbauer, S.
    Mamat, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S159 - S159
  • [26] An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
    Morgenstern, Alfred
    Apostolidis, Christos
    Kratochwil, Clemens
    Sathekge, Mike
    Krolicki, Leszek
    Bruchertseifer, Frank
    CURRENT RADIOPHARMACEUTICALS, 2018, 11 (03) : 200 - 208
  • [27] Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Boll, RA
    Malkemus, DW
    Mirzadeh, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U258 - U258
  • [28] Production and purification of radium-225/actinium-225 at TRIUMF's ISOL facility and subsequent radiolabeling studies with alpha-emitting daughter actinium-225
    Ramogida, Caterina F.
    Robertson, Andrew K. H.
    Kunz, Peter
    Bratanovic, Ivica
    Spreckelmeyer, Sarah
    Lassen, Jens
    Orvig, Chris
    Schaffer, Paul
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S25 - S25
  • [29] Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
    Qin, Yun
    Imobersteg, Stefan
    Blanc, Alain
    Frank, Stephan
    Schibli, Roger
    Behe, Martin P.
    Grzmil, Michal
    PHARMACEUTICS, 2020, 12 (11) : 1 - 12
  • [30] Qualitative and quantitative SPECT/CT imaging of actinium-225 for targeted therapy of gliomas phantom studies.
    Tulik, M.
    Kulinski, R.
    Tabor, Z.
    Brzozowska, B.
    Laba, P.
    Bruchertseifer, F.
    Morgenstern, A.
    Krolicki, L.
    Kunikowska, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S801 - S802
12345